Mr. Mehalick is a co-founder of Coeptis Pharmaceuticals and serves as Chief Executive Officer. Dave is responsible for implementing long and short-term initiatives and overseeing fundraising planning and implementation.
A serial entrepreneur, Dave also founded and is President of Steeltown Consulting Group where he co-founded American Defense Systems (IPO), World Health Alternatives (IPO), American Scientific Resources (IPO), and Myotrend Nutritional Technologies (sold Privately).
At Steeltown Consulting Group, Dave served as an advisor to many companies including; Cyberdefender, Immune Therapeutics, American Standard Energy, TNI Biotech, Delmar Pharmaceuticals, Cytocom, and Spectral Molecular Imaging.
Shortly after his time at the University of Pittsburgh, Dave held the positions of First Vice President at Gruntal and Co. and Senior Vice President at First Union Capital Markets at Ferris, Baker Watts.
Dave is active in many non-profits including the International Myeloma Foundation, The Family House of Pittsburgh, and the North Pittsburgh Catholic Ironmen.